On August 10, 2025, Zhejiang Aoxiang Pharmaceutical Co., Ltd. conducted a one-day on-site audit of our company's product 2-chloro-4-methylpyrimidine (CAS: 13036-57-2).
The auditors conducted a detailed inspection of our company's quality system documents, production site, laboratory, warehouse, production and inspection records, etc., and put forward several general issues and rectification suggestions.
Our company will actively implement and rectify the issues raised, and the audit will be successfully accepted!